Pharmaceutical companies have raised prices on hundreds of drugs so far this month despite federal efforts to rein in drug ...

Unfortunately, the Trump administration has proposed a cure that’s worse than the disease. It’s called “most-favored nation,” ...

Congress has yet again reached a bipartisan agreement on a suite of policies targeting the business practices of the drug ...

Despite previous proposed cuts, under the latest version, the agency would receive the same funding as last year.

The Centers for Medicare & Medicaid Services prepares to implement a historic financial adjustment affecting millions of ...

The commercialisation of the industry as private equity owners take over from pioneering doctors has many people worried.

GoodRx reports five major changes to Medicare in 2026, including a $2,100 Part D out-of-pocket limit, prior authorization for ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

A new study examines the potential impact of the Medicare Prescription Payment Plan (M3P)—an opt-in policy implemented in ...

The post ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs appeared first on ProPublica.

Are you among those who can expect a discount on prescription drugs?

Pharmacy groups back PBM reforms in Medicare Part D to improve contract enforcement, appeals, and curb drug costs in the 2026 spending package.